Literature DB >> 16945530

Syntheses and studies of quinolone-cephalosporins as potential anti-tuberculosis agents.

Gaiying Zhao1, Marvin J Miller, Scott Franzblau, Baojie Wan, Ute Möllmann.   

Abstract

The syntheses and anti-tuberculosis activity of quinolone-cephalosporin conjugates (1 and 2) are described. Both showed broad-spectrum antibacterial activity and significant anti-TB activity. The carbamate-linked quinolone-cephem 2 showed better antimycobacterial activity, including anti-TB activity, than the direct amine-linked quinolone-cephem 1, while quinolone-cephem 1 was slightly more effective against some Gram-negative bacterial strains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945530     DOI: 10.1016/j.bmcl.2006.08.045

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Syntheses and biological evaluation of new cephalosporin-oxazolidinone conjugates.

Authors:  Shanshan Yan; Marvin J Miller; Timothy A Wencewicz; Ute Möollmann
Journal:  Medchemcomm       Date:  2010-05-05       Impact factor: 3.597

2.  Copper Influences the Antibacterial Outcomes of a β-Lactamase-Activated Prochelator against Drug-Resistant Bacteria.

Authors:  Jacqueline M Zaengle-Barone; Abigail C Jackson; David M Besse; Bradford Becken; Mehreen Arshad; Patrick C Seed; Katherine J Franz
Journal:  ACS Infect Dis       Date:  2018-03-26       Impact factor: 5.084

3.  Enzymatic deprotection of the cephalosporin 3'-acetoxy group using Candida antarctica lipase B.

Authors:  Leslie D Patterson; Marvin J Miller
Journal:  J Org Chem       Date:  2010-02-19       Impact factor: 4.354

4.  One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria.

Authors:  Garrett C Moraski; Jane A Thanassi; Steven D Podos; Michael J Pucci; Marvin J Miller
Journal:  J Antibiot (Tokyo)       Date:  2011-08-03       Impact factor: 2.649

5.  A conventional HPLC-MS method for the simultaneous determination of ofloxacin and cefixime in plasma: Development and validation.

Authors:  Mahesh V Attimarad; Ahmed O Alnajjar
Journal:  J Basic Clin Pharm       Date:  2013-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.